Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;12(6):e899.
doi: 10.1002/ctm2.899.

Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role

Affiliations

Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role

Nathalie Garnier et al. Clin Transl Med. 2022 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
miRNA expression in non‐severe compared to severe COVID‐19. (A) Number of miRNAs detected in nasopharyngeal swab specimens of severe (n = 20), non‐severe COVID‐19 (n = 21) and controls (n = 20). Box plots showing median and interquartile ranges of the number of expressed miRNAs in each group. (B) Box‐plots showing the expression of miRNAs that are differentially expressed between severe (S) and non‐severe (NS) COVID‐19 and control groups (Ctrl) in univariate analyses (panels Ba,b). Box‐plots showing the expression of miRNAs that discriminate severe and non‐severe COVID‐19 by the sPLS‐DA multivariate analysis (panels Bb,c). The miRNAs identified by both analyses are shown in panel Bb. The bars show the medians and the boxes the interquartile ranges of normalized miRNA expression. (C) Severe (S, triangles) and non‐severe COVID‐19 cases (NS, circles) are discriminated by miRNA expression by sPLS‐DA analysis
FIGURE 2
FIGURE 2
Receiver operator characteristic (ROC) analysis for the discrimination of severe and non‐severe COVID‐19. ROC curve and area under the ROC curve (AUC) values for the classification into severe and non‐severe COVID‐19 based on miRNA expression are shown for the three miRNAs identified in common by sPLS‐DA and univariate analysis

References

    1. Wilson JC, Kealy D, James SR, et al. Integrated miRNA/cytokine/chemokine profiling reveals severity‐associated step changes and principal correlates of fatality in COVID‐19. iScience. 2022;25:103672. 10.1016/j.isci.2021.103672 - DOI - PMC - PubMed
    1. Takahashi T, Heaton SM, Parrish NF. Mammalian antiviral systems directed by small RNA. PLoS Pathog. 2021;17:e1010091. 10.1371/journal.ppat.1010091 - DOI - PMC - PubMed
    1. Libri V, Miesen P, van Rij RP, Buck AH. Regulation of microRNA biogenesis and turnover by animals and their viruses. Cell Mol Life Sci. 2013;70:3525‐3544. 10.1007/s00018-012-1257-1 - DOI - PMC - PubMed
    1. Mousavi SR, Sajjadi MS, Khosravian F, et al. Dysregulation of RNA interference components in COVID‐19 patients. BMC Res Notes. 2021;14:401. 10.1186/s13104-021-05816-0 - DOI - PMC - PubMed
    1. Aguado LC, Schmid S, Sachs D, et al. microRNA function is limited to cytokine control in the acute response to virus infection. Cell Host Microbe. 2015;18:714‐722. 10.1016/j.chom.2015.11.003 - DOI - PMC - PubMed

Publication types

LinkOut - more resources